Neuro

Delirium in Cancer

search

Delirium in Cancer, Delirium in Terminally Ill Patients, Cancer Related Delirium, Mental Status Changes Near End of Life, Terminal Delirium

  • Epidemiology
  1. Delirium Incidence in terminally ill patients: 25 to 85%
  2. Sedation required in 25% of patients
  3. Reversible in 50% of patients
  • Risk Factors
  1. Impaired Vision (Snellen Chart <20/70)
  2. Severe illness
  3. Cognitive Impairment (Mini-Mental State Exam <24)
  4. Major Depression (Mood Disorders in Cancer)
  5. Emotional stress
  6. Unfamiliar environment
  7. Immobilization
  • Management
  1. See Delirium
  2. Consider potentially reversible causes above
  3. Consider gentle rehydration if Dehydration suspected
  4. Reduce risk factors above
  5. Family member or sitter presence may calm patient
  6. Avoid precipitating events
    1. Avoid Physical Restraints
    2. Avoid Malnutrition
    3. Avoid adding more than three medications per day
    4. Avoid Bladder Catheterization
    5. Avoid frequent changes in environment or staff
  7. Consider medications for Delirium with Agitation refractory to other measures
    1. Haloperidol 0.5 to 5 mg PO, IV, SC, IM q2 to 12 hours
    2. Agents with adverse effects but long response delay
      1. Risperidone
      2. Clozapine
      3. Olanzapine
  8. Consider short-acting sedation if refractory to above (risk of paradoxical Agitation)
    1. Lorazepam
    2. Midazolam
    3. Other measures reportedly used include Propofol (caution!!)
  9. Other measures
    1. Methadone
      1. Moryl (2005) Palliat Support Care 3(4): 311-7 [PubMed]